10-Q Filing

UNITEDHEALTH GROUP INC CIK: 731766 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0000731766-22-000036`
Period End Date	20220630
Filing Date	20220803
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	unh-20220630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 84 Cash Flow Statement 74 Stockholders Equity 62 Comprehensive Income 48

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.38B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.61B	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$3.35B	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$2.53B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$18.72B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$14.22B	USD	Point-in-time
Other current receivables, net	`OtherReceivablesNetCurrent`	$12.44B	USD	Point-in-time
Other current receivables, net	`OtherReceivablesNetCurrent`	$13.87B	USD	Point-in-time
Assets under management	`AarpAssetsUnderManagement`	$4.45B	USD	Point-in-time
Assets under management	`AarpAssetsUnderManagement`	$4.02B	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.32B	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.22B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$61.76B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$68.36B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$43.11B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$42.43B	USD	Point-in-time
Property, equipment and capitalized software, net	`PropertyPlantAndEquipmentNet`	$8.97B	USD	Point-in-time
Property, equipment and capitalized software, net	`PropertyPlantAndEquipmentNet`	$9.42B	USD	Point-in-time
Goodwill	`Goodwill`	$75.80B	USD	Point-in-time
Goodwill	`Goodwill`	$84.16B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$11.29B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$10.04B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$14.52B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$12.53B	USD	Point-in-time
Total assets	`Assets`	$212.21B	USD	Point-in-time
Total assets	`Assets`	$230.17B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$21.87B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$28.98B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$25.13B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$24.48B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$24.64B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$25.14B	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt	`DebtCurrent`	$5.59B	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt	`DebtCurrent`	$3.62B	USD	Point-in-time
Unearned revenues	`DeferredRevenueCurrent`	$2.21B	USD	Point-in-time
Unearned revenues	`DeferredRevenueCurrent`	$2.57B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$22.98B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$26.77B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$78.29B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$88.70B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtNoncurrent`	$42.38B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtNoncurrent`	$45.80B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.27B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.58B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$11.79B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$11.97B	USD	Point-in-time
Total liabilities	`Liabilities`	$149.04B	USD	Point-in-time
Total liabilities	`Liabilities`	$135.73B	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$4.92B	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$1.43B	USD	Point-in-time
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value - 3,000 shares authorized; 935 and 941 issued and outstanding	`CommonStockValue`	$10.00M	USD	Point-in-time
Common stock, $0.01 par value - 3,000 shares authorized; 935 and 941 issued and outstanding	`CommonStockValue`	$10.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$77.13B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$80.54B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-7.73B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.38B	USD	Point-in-time
Nonredeemable noncontrolling interests	`MinorityInterest`	$3.29B	USD	Point-in-time
Nonredeemable noncontrolling interests	`MinorityInterest`	$3.38B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.05B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.20B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.13B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.33B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$72.02B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.31B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and equity	`LiabilitiesAndStockholdersEquity`	$212.21B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and equity	`LiabilitiesAndStockholdersEquity`	$230.17B	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	3.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	3.00B	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	935.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	941.00M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	941.00M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	935.00M	shares	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$111.72B	USD	2 Qtrs
Premiums	`PremiumsEarnedNet`	$63.90B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$56.23B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$127.97B	USD	2 Qtrs
Investment and other income	`InvestmentIncomeInterestAndDividend`	$1.01B	USD	2 Qtrs
Investment and other income	`InvestmentIncomeInterestAndDividend`	$556.00M	USD	1 Quarter
Investment and other income	`InvestmentIncomeInterestAndDividend`	$295.00M	USD	1 Quarter
Investment and other income	`InvestmentIncomeInterestAndDividend`	$662.00M	USD	2 Qtrs
Total revenues	`Revenues`	$71.32B	USD	1 Quarter
Total revenues	`Revenues`	$141.52B	USD	2 Qtrs
Total revenues	`Revenues`	$160.48B	USD	2 Qtrs
Total revenues	`Revenues`	$80.33B	USD	1 Quarter
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$52.09B	USD	1 Quarter
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$91.45B	USD	2 Qtrs
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$46.55B	USD	1 Quarter
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$104.62B	USD	2 Qtrs
Operating costs	`SellingGeneralAndAdministrativeExpense`	$23.11B	USD	2 Qtrs
Operating costs	`SellingGeneralAndAdministrativeExpense`	$20.58B	USD	2 Qtrs
Operating costs	`SellingGeneralAndAdministrativeExpense`	$10.36B	USD	1 Quarter
Operating costs	`SellingGeneralAndAdministrativeExpense`	$11.71B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$15.23B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$17.08B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$7.66B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$8.60B	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$778.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$802.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.54B	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.59B	USD	2 Qtrs
Total operating costs	`CostsAndExpenses`	$73.20B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$128.80B	USD	2 Qtrs
Total operating costs	`CostsAndExpenses`	$146.40B	USD	2 Qtrs
Total operating costs	`CostsAndExpenses`	$65.34B	USD	1 Quarter
Earnings from operations	`OperatingIncomeLoss`	$14.08B	USD	2 Qtrs
Earnings from operations	`OperatingIncomeLoss`	$12.72B	USD	2 Qtrs
Earnings from operations	`OperatingIncomeLoss`	$7.13B	USD	1 Quarter
Earnings from operations	`OperatingIncomeLoss`	$5.98B	USD	1 Quarter
Interest expense	`InterestExpense`	$467.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$807.00M	USD	2 Qtrs
Interest expense	`InterestExpense`	$410.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$900.00M	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.57B	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$6.67B	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$13.18B	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$11.91B	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$2.83B	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$2.56B	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.47B	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.20B	USD	1 Quarter
Net earnings	`ProfitLoss`	$9.35B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$10.35B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$5.20B	USD	1 Quarter
Net earnings	`ProfitLoss`	$4.37B	USD	1 Quarter
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$250.00M	USD	2 Qtrs
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$129.00M	USD	1 Quarter
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$222.00M	USD	2 Qtrs
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$106.00M	USD	1 Quarter
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$4.27B	USD	1 Quarter
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$10.10B	USD	2 Qtrs
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$5.07B	USD	1 Quarter
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$9.13B	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$9.66	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$4.52	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$10.75	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$5.41	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$5.34	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$9.55	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$4.46	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$10.61	USD	2 Qtrs
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	945.00M	shares	2 Qtrs
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	939.00M	shares	2 Qtrs
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	937.00M	shares	1 Quarter
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	944.00M	shares	1 Quarter
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	13.00M	shares	2 Qtrs
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	13.00M	shares	1 Quarter
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	12.00M	shares	1 Quarter
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	11.00M	shares	2 Qtrs
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	956.00M	shares	2 Qtrs
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	952.00M	shares	2 Qtrs
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	956.00M	shares	1 Quarter
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	950.00M	shares	1 Quarter
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	3.00M	shares	1 Quarter
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	2.00M	shares	2 Qtrs
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	1.00M	shares	1 Quarter
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	3.00M	shares	2 Qtrs

Cash Flow Statement 74 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$9.35B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$10.35B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$5.20B	USD	1 Quarter
Net earnings	`ProfitLoss`	$4.37B	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$778.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$802.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.54B	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.59B	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$327.00M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-15.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$504.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$426.00M	USD	2 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$-215.00M	USD	2 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$214.00M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$4.20B	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.22B	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$643.00M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.52B	USD	2 Qtrs
Medical costs payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$3.09B	USD	2 Qtrs
Medical costs payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$4.03B	USD	2 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$807.00M	USD	2 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$298.00M	USD	2 Qtrs
Unearned revenues	`IncreaseDecreaseInDeferredRevenue`	$-523.00M	USD	2 Qtrs
Unearned revenues	`IncreaseDecreaseInDeferredRevenue`	$-440.00M	USD	2 Qtrs
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$12.19B	USD	2 Qtrs
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$11.54B	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$8.90B	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$8.85B	USD	2 Qtrs
Sales of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$1.41B	USD	2 Qtrs
Sales of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$2.35B	USD	2 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$4.65B	USD	2 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$3.19B	USD	2 Qtrs
Cash paid for acquisitions, net of cash assumed	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$7.15B	USD	2 Qtrs
Cash paid for acquisitions, net of cash assumed	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$4.64B	USD	2 Qtrs
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.21B	USD	2 Qtrs
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.13B	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$648.00M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$532.00M	USD	2 Qtrs
Cash flows used for investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-12.26B	USD	2 Qtrs
Cash flows used for investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.21B	USD	2 Qtrs
Common share repurchases	`PaymentsForRepurchaseOfCommonStock`	$5.00B	USD	2 Qtrs
Common share repurchases	`PaymentsForRepurchaseOfCommonStock`	$2.90B	USD	2 Qtrs
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.54B	USD	Point-in-time
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$2.55B	USD	2 Qtrs
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.36B	USD	Point-in-time
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$2.91B	USD	2 Qtrs
Proceeds from common stock issuances	`ProceedsFromIssuanceOfCommonStock`	$756.00M	USD	2 Qtrs
Proceeds from common stock issuances	`ProceedsFromIssuanceOfCommonStock`	$764.00M	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.90B	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.10B	USD	2 Qtrs
Proceeds from (repayments of) short-term borrowings, net	`ProceedsFromRepaymentsOfCommercialPaper`	$1.34B	USD	2 Qtrs
Proceeds from (repayments of) short-term borrowings, net	`ProceedsFromRepaymentsOfCommercialPaper`	$-176.00M	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$5.92B	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$6.93B	USD	2 Qtrs
Customer funds administered	`IncreaseDecreaseInDeposits`	$5.79B	USD	2 Qtrs
Customer funds administered	`IncreaseDecreaseInDeposits`	$2.40B	USD	2 Qtrs
Purchases of redeemable noncontrolling interests	`PaymentsForRepurchaseOfRedeemableNoncontrollingInterest`	$97.00M	USD	2 Qtrs
Purchases of redeemable noncontrolling interests	`PaymentsForRepurchaseOfRedeemableNoncontrollingInterest`	$1.34B	USD	2 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-662.00M	USD	2 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.45B	USD	2 Qtrs
Cash flows used for financing activities	`NetCashProvidedByUsedInFinancingActivities`	$569.00M	USD	2 Qtrs
Cash flows used for financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.25B	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.00M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$57.00M	USD	2 Qtrs
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$3.24B	USD	2 Qtrs
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.91B	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.92B	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$24.61B	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.83B	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$21.38B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.92B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$24.61B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.83B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$21.38B	USD	Point-in-time

Stockholders Equity 62 line items

Line Item	Tag	Value	Unit	Period
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$3.10	USD	2 Qtrs
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.45	USD	Point-in-time
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.45	USD	1 Quarter
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.65	USD	1 Quarter
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.65	USD	Point-in-time
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$2.70	USD	2 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.05B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.20B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.13B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.33B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$72.02B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.31B	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	941.00M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	935.00M	shares	Point-in-time
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$4.27B	USD	1 Quarter
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$10.10B	USD	2 Qtrs
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$5.07B	USD	1 Quarter
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$9.13B	USD	2 Qtrs
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$5.16B	USD	1 Quarter
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$4.35B	USD	1 Quarter
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$10.28B	USD	2 Qtrs
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$9.30B	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-272.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$740.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-2.35B	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-1.70B	USD	1 Quarter
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$174.00M	USD	1 Quarter
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$292.00M	USD	1 Quarter
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$507.00M	USD	2 Qtrs
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$548.00M	USD	2 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$194.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$476.00M	USD	2 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$158.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$400.00M	USD	2 Qtrs
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$1.25B	USD	1 Quarter
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$2.50B	USD	1 Quarter
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$2.90B	USD	2 Qtrs
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$5.00B	USD	2 Qtrs
Cash dividends paid on common shares	`DividendsCash`	$2.55B	USD	2 Qtrs
Cash dividends paid on common shares	`DividendsCash`	$1.37B	USD	1 Quarter
Cash dividends paid on common shares	`DividendsCash`	$2.91B	USD	2 Qtrs
Cash dividends paid on common shares	`DividendsCash`	$1.54B	USD	1 Quarter
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$365.00M	USD	1 Quarter
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$-229.00M	USD	1 Quarter
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$-833.00M	USD	2 Qtrs
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$234.00M	USD	2 Qtrs
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$85.00M	USD	1 Quarter
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$103.00M	USD	2 Qtrs
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$12.00M	USD	1 Quarter
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$151.00M	USD	2 Qtrs
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$148.00M	USD	2 Qtrs
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$83.00M	USD	1 Quarter
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$185.00M	USD	2 Qtrs
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$74.00M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.05B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.20B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.13B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.33B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$72.02B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.31B	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	941.00M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	935.00M	shares	Point-in-time

Comprehensive Income 48 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$9.35B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$10.35B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$5.20B	USD	1 Quarter
Net earnings	`ProfitLoss`	$4.37B	USD	1 Quarter
Gross unrealized (losses) gains on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$251.00M	USD	1 Quarter
Gross unrealized (losses) gains on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-513.00M	USD	2 Qtrs
Gross unrealized (losses) gains on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-1.33B	USD	1 Quarter
Gross unrealized (losses) gains on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-3.35B	USD	2 Qtrs
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$58.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-769.00M	USD	2 Qtrs
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-304.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-116.00M	USD	2 Qtrs
Total unrealized (losses) gains, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.03B	USD	1 Quarter
Total unrealized (losses) gains, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$193.00M	USD	1 Quarter
Total unrealized (losses) gains, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.58B	USD	2 Qtrs
Total unrealized (losses) gains, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-397.00M	USD	2 Qtrs
Gross reclassification adjustment for net realized gains included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$1.00M	USD	1 Quarter
Gross reclassification adjustment for net realized gains included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$4.00M	USD	2 Qtrs
Gross reclassification adjustment for net realized gains included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$9.00M	USD	1 Quarter
Gross reclassification adjustment for net realized gains included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$16.00M	USD	2 Qtrs
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$2.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	-	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$4.00M	USD	2 Qtrs
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$1.00M	USD	2 Qtrs
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$1.00M	USD	1 Quarter
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$12.00M	USD	2 Qtrs
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$3.00M	USD	2 Qtrs
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$7.00M	USD	1 Quarter
Total foreign currency translation (losses) gains	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$137.00M	USD	2 Qtrs
Total foreign currency translation (losses) gains	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-676.00M	USD	1 Quarter
Total foreign currency translation (losses) gains	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$554.00M	USD	1 Quarter
Total foreign currency translation (losses) gains	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$242.00M	USD	2 Qtrs
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-272.00M	USD	2 Qtrs
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$740.00M	USD	1 Quarter
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-2.35B	USD	2 Qtrs
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-1.70B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.11B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.50B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$8.00B	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$9.08B	USD	2 Qtrs
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$222.00M	USD	2 Qtrs
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$250.00M	USD	2 Qtrs
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$106.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$129.00M	USD	1 Quarter
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$5.01B	USD	1 Quarter
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$3.37B	USD	1 Quarter
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$7.75B	USD	2 Qtrs
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$8.86B	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.